Search by Drug Name or NDC
NDC 62756-0301-01 SEZABY 100 mg/1 Details
SEZABY 100 mg/1
SEZABY is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sun Pharmaceutical Industries, Inc.. The primary component is PHENOBARBITAL SODIUM.
Product Information
| NDC | 62756-0301 |
|---|---|
| Product ID | 62756-301_6ac5c671-68ab-4347-9cd6-1fd6ef32b069 |
| Associated GPIs | |
| GCN Sequence Number | 084058 |
| GCN Sequence Number Description | phenobarbital sodium VIAL 100 MG INTRAVEN |
| HIC3 | H2D |
| HIC3 Description | BARBITURATES |
| GCN | 53189 |
| HICL Sequence Number | 001560 |
| HICL Sequence Number Description | PHENOBARBITAL SODIUM |
| Brand/Generic | Brand |
| Proprietary Name | SEZABY |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | phenobarbital sodium |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/1 |
| Substance Name | PHENOBARBITAL SODIUM |
| Labeler Name | Sun Pharmaceutical Industries, Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | CIV |
| Marketing Category | NDA |
| Application Number | NDA215910 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62756-0301-01 (62756030101)
| NDC Package Code | 62756-301-01 |
|---|---|
| Billing NDC | 62756030101 |
| Package | 1 INJECTION in 1 VIAL, SINGLE-DOSE (62756-301-01) |
| Marketing Start Date | 2022-12-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |